genprowebdirectory
GEN Edge
News
Insights
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
GEN Edge
Cytiva Picks Up Where GE Leaves Off after $21B Deal
Artificial Intelligence
Putting COVID-19 on the ‘Map’
GEN Edge
Athersys Stem Cell Therapy Targets Top Cause of COVID-19 Deaths
GEN Edge
Cellectis’ New Patent Supports CRISPR-Based T-Cell Immunotherapies
GEN Edge
Top 15 Best-Selling Drugs of 2019
News
Coronavirus
Coronavirus Picks on Some Cells More Than Others
News
Fruit Compound Reduces and Helps Repair Damage in MS Models
Bioprocessing
Akron Biotech Expands to Second US Manufacturing Facility
Coronavirus
COVID-19 and Cats: Bronx Zoo Tiger Tests Positive
Coronavirus
MERS Vaccine that Fully Protects Mice Used as Basis for Coronavirus…
Insights
All
Trends for 2020
Cell Therapy
Cell and Gene Therapy Sector Needs to Automate
Bioprocessing
The Right Start is Crucial
Bioprocessing
Going from Small to Big in Bioprocessing: Roadblocks and Their Resolution
Commentary
Understanding Glycans in COVID-19 Drug Design
A-Lists
Gilead Sciences
Catching Up to Coronavirus: Top 60 Treatments in Development
GEN Edge
Top 15 Best-Selling Drugs of 2019
Coronavirus
How to Conquer Coronavirus: Top 35 Treatments in Development
Insights
Top 10 Life Sciences Jobs Most in Demand over the Next…
GEN Edge
Ten Life Science Analysts to Watch in 2020
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Coronavirus
Coronavirus Picks on Some Cells More Than Others
Cell Therapy
Cell and Gene Therapy Sector Needs to Automate
Bioprocessing
Akron Biotech Expands to Second US Manufacturing Facility
Bioprocessing
The Right Start is Crucial
Magazine
March 2020 Vol. 40 No. 3
Expanding the CRISPR Toolbox
Commentary
Strategies for Optimizing CRISPR-Cas9 Delivery into Hard-to-Transfect Cells
March 2020 Vol. 40 No. 3
RNA Silencing Finds Its Therapeutic Voice
March 2020 Vol. 40 No. 3
Genomic Medicine Identifies Reconcilable Differences
Commentary
Hasten Genomic Medicine’s Rise with Advanced Data Management
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Upcoming Webinars
Feel the Flow: Immune Cell Signaling Cascades Reveal Phenotype and Function
April 2020 Vol. 40 No.4
A New Lease on Life for shRNA
April 2020 Vol. 40 No.4
To Improve Protein Aggregation Assessments, Combine PCT and MMS
April 2020 Vol. 40 No.4
Protein Labeling Kit
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Therapeutics
Generics
Generics
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Generics
Personalized, Combination Therapies Improve Cancer Patient Outcomes
Generics
Teva Axing 14,000 Positions, Shutting Facilities Worldwide
Generics
Gilead Licenses Rights for HIV-1 Treatment BIC
Generics
FDA Commits to Advancing Generics with New List, Faster Reviews
Generics
Perrigo Confirms Office Search by U.S. Justice Department
Generics
Teva to Shrink Workforce; Denies Up to 6,000 Jobs Will Go
Generics
Apotex Plans 150 New Jobs in $184M U.S. Expansion
Generics
Fresenius Kabi Earmarks $250M for Illinois Manufacturing Site Expansion
Generics
After Completing $39B Acquisition, Teva Does Another Generics Deal with Allergan
Generics
Sagent Buys Five ANDAs, Including Propofol, from Teva for $40M
Generics
Mylan to Acquire Meda for $9.9B
Generics
Mylan to Sell Seven Generics to Alvogen as FTC Clears Perrigo...
Generics
Biopharma Industry Blasts TPP Exclusivity Compromise
Generics
Merck & Co. Sells 2 NDAs to ANI Pharmaceuticals for $75M+
Load more
Scroll Up
Please wait while you are redirected to the right page...
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
